Zalevsky Jonathan sold NKTR
June 30, 2026 · Form 4 insider transaction
Zalevsky Jonathan sold 5,681 shares of Nektar Therapeutics at $70.00 per share, a transaction worth $397.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,681
Price
$70.00
Total value
$397.7K
InsiderZalevsky Jonathan
RoleOfficer
CompanyNektar Therapeutics (NKTR)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after9,756
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.